Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Berlusconi's women
A look at the women linked to former Italian Prime Minister Silvio Berlusconi. Slideshow
Harvesting tobacco
With the increasing health concerns with smoking in the U.S., traditional tobacco farmers sell their crop to growing markets outside the country. Slideshow
Sponsored Links
Cubist to buy Trius Therapeutics, Optimer Pharma for up to $1.62 billion
(Reuters) - Cubist Pharmaceuticals Inc said it would buy Trius Therapeutics Inc and Optimer Pharmaceuticals Inc for up to $1.62 billion to boost its antibiotics portfolio.
Cubist said it would buy all outstanding shares of Optimer for a total of $15.75 per share in cash, including contingency payments. The offer represents a premium of 18 percent on Tuesday's closing price.
Cubist said it would pay a total of $15.50 per share for Trius, including contingency payments. The offer represents a premium of 32 percent to the stock's closing price on Tuesday.
(This story is corrected in paragraphs 2 and 3 to say the per-share offers include contingency payments)
(Reporting By Vrinda Manocha in Bangalore; Editing by Maju Samuel)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints




Follow Reuters